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Concordance between programmed stimulation and 24 
hour ambulatory electrocardiographic (Holter) moni-
toring was studied in 54 patients with sustained ven-
tricular tachycardia during 84 therapeutic trials with 
class IA antiarrhythmic agents. During baseline studies 
before treatment, all patients had frequent (2: 30/h) ven-
tricular premature complexes on Holter recordings and 
sustained ventricular tachycardia inducible by one to 
three extrastimuli. During treatment, programmed 
stimulation and Holter monitoring were repeated. Ef-
ficacy of treatment determined by programmed stimu-
lation (ventricular tachycardia no longer inducible or 
nonsustained) was compared with three Holter criteria 
of efficacy: I = 83% or more reduction of ventricular 
premature complexes and abolition of ventricular tachy-
cardia; II = 50% or more reduction of ventricular pre-
mature complexes and 90% or more reduction of cou-
plets and abolition of ventricular tachycardia; III = 
abolition of ventricular tachycardia in patients with ven-
tricular tachycardia during a baseline Holter recording. 
Treatments were judged effective by programmed 
stimulation criteria in only 25% of cases but in 51, 63 
There are different approaches to the management of pa-
tients with sustained symptomatic ventricular tachycardia 
or out of hospital cardiac arrest (1-10). Two commonly 
used approaches are 1) programmed stimulation (5-10), and 
2) reduction of frequent and complex ventricular premature 
complexes using ambulatory (Holter) monitoring (1-4). Each 
approach has been used individually by many investigators 
(1-10) with very good reported predictive value. However, 
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and 75% of cases by Holter criterion I, II and III, re-
spectively. Results of programmed stimulation and Hol-
ter monitor were discordant (effective by one criterion 
but ineffective by the other) in 50% of cases using Holter 
criterion I, in 54% using Holter criterion II and in 61 % 
using Holter criterion III. In the majority of discordant 
results, treatments appeared efficacious by Holter cri-
teria but ineffective by programmed stimulation criteria, 
suggesting insensitivity of efficacy by Holter criteria or 
nonspecificity of induced ventricular tachycardia during 
treatment, or both. 
Conclusions: I) programmed stimulation and Holter 
monitor recording are discordant in assessing efficacy 
of class IA antiarrhythmic agents; 2) efficacy by Holter 
criteria is often easier to achieve than efficacy by pro-
grammed stimulation (p < 0.001); and 3) the discor-
dance between the two methods, both with very good 
reported predictive values, calls for long-term follow-up 
studies to determine sensitivity and specificity of each 
method. 
(J Am Coli CardioI1985;6:539-44) 
data regarding any correlation between programmed stim-
ulation and ambulatory monitoring are limited (II), and no 
study has been done to determine the degree of concordance 
between programmed stimulation and Holter monitoring in 
assessing the efficacy of antiarrhythmic agents. To evaluate 
the correlation between these two approaches we have ap-
plied both programmed stimulation and ambulatory moni-
toring concurrently in 54 patients with recurrent sustained 
ventricular tachycardia with hemodynamic compromise or 
ventricular fibrillation during 84 treatments with class IA 
antiarrhythmic agents. 
Methods 
Patient selection. Fifty-four patients were studied. They 
all had recurrent sustained ventricular tachycardia with 
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hemodynamic compromise or ventricular fibrillation. None 
of the arrhythmias was associated with acute myocardial 
infarction or remediable causes (such as hypokalemia, dig-
itoxicity or drug-induced arrhythmia). Criteria for admission 
to the study also included frequent (2::30/h) ventricular 
premature complexes on Holter monitoring (1,12) and in-
ducible sustained (13,14) ventricular arrhythmia by pro-
grammed stimulation requiring intervention for termination 
during a baseline study in the absence of antiarrhythmic 
agents. 
Ambulatory electrocardiographic monitoring. Con-
tinuous 24 hour ambulatory electrocardiograms were re-
corded on an Avionics 445 two-channel recorder. Analysis 
of the tape was done on a computerized Cardio Data System 
scanner. The total number of ventricular premature com-
plexes, couplets and non sustained ventricular tachycardia 
(2::3 ventricular premature complexes at a rate faster than 
100 beats/min) were generated by the scanner. Accuracy of 
the system was tested by the blind insertion of quality control 
tapes into the analyst's normal work load. Standard data 
used for accuracy determination were generated through 
trendscription of the entire 24 hour period; the recorded data 
were then hand-counted for quantification of all ventricular 
ectopic activity. 
Accuracy was calculated using the following formula: 
(HS-RT) 
100 - RT x 100 = accuracy (%), 
where HS == high speed and RT == real time. Accuracy of 
total ventricular premature complex count was 96.3 ± 3.7%, 
couplets 93.7 ± 6.7 % and ventricular tachycardia 96.2 ± 
5.8%. The results were verified by one of the investigators. 
Mean ventricular premature complex count or couplets was 
calculated by dividing the total number of ventricular pre-
mature beats or couplets by the number of hours recorded. 
Programmed stimulation. Programmed stimulation was 
performed initially at the right ventricular apex in all pa-
tients. When ventricular tachycardia was not inducible at 
the right ventricular apex, the right ventricular outflow tract 
was stimulated. Single (Sz), double (S2S3) or triple (SZSjS4) 
premature stimuli were introduced during sinus rhythm (SIS.) 
and during ventricular pacing (S.S.) at cycle lengths of 600 
to 400 ms. A single premature stimulus (Sz) was introduced 
in late diastole and the coupling interval was gradually short-
ened by 10 ms until ventricular tachycardia was induced or 
until the effective refractory period of the ventricle was 
reached. When double extrastimuli (S2S3) were necessary 
for induction of ventricular tachycardia, Sz was introduced 
at an interval 10 ms longer than the effective refractory 
period and S3 was introduced at gradually shorter coupling 
intervals until ventricular tachycardia was induced or until 
the effective refractory period was reached. A third extras-
timulus (S4) was introduced, if needed, in a manner anal-
ogous to that for S3' 
Study design. Informed consent was obtained from all 
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patients before the study for serial drug testing by pro-
grammed stimulation and ambulatory electrocardiographic 
monitoring. All patients had a baseline 24 hour ambulatory 
electrocardiogram and programmed stimulation study at least 
five half-lives after discontinuation of all antiarrhythmic 
medications. If needed for other reasons, digoxin or pro-
pranolol, or both, was continued throughout the study. After 
the baseline studies, administration of a class IA antiar-
rhythmic agent (procainamide, quinidine or disopyramide) 
was started. The dose of the agent was adjusted to the 
maximum as tolerated by the patient. Programmed stimu-
lation and 24 hour ambulatory monitoring were repeated 
after the patient had received an antiarrhythmic agent at a 
constant dose for at least five doses to ensure steady state 
blood levels. Some patients were studied sequentially taking 
more than one agent, each used separately, by concurrent 
ambulatory monitoring and programmed stimulation. 
Data analysis. Results of concurrent ambulatory mon-
itoring and programmed stimulation during each treatment 
in each patient were compared for concordance of efficacy. 
Three criteria were used for efficacy by Holter monitoring: 
Criterion I == 83% or greater reduction of ventricular 
premature complexes (15) and abolition of ventricular tachy-
cardia (1-4). 
Criterion /I = 50% or greater reduction of ventricular 
premature complexes and 90% or greater reduction of cou-
plets and abolition of ventricular tachycardia (1,2). 
Criterion 11/ == abolition of ventricular tachycardia in 
patients who had ventricular tachycardia during a baseline 
Holter recording (3,4). 
Programmed stimulation criteria. A treatment was con-
sidered effective when previously induced ventricular tachy-
cardia was no longer inducible (5-10) or nonsustained (::SIS 
beats in duration) (16). 
Statistical analysis. Concordance or discordance be-
tween ambulatory monitoring and programmed stimulation 
in assessing efficacy or inefficacy of drugs was tested by 
McNemar's test. 
Results 
Patient characteristics. Of the 54 patients studied, 46 
were men and 8 were women with an average age (± SD) 
of 58 ± 12 years. Fifty-one patients had symptomatic re-
current sustained ventricular tachycardia; in three patients, 
the first documented arrhythmia was ventricular fibrillation. 
Forty-seven patients had coronary artery disease with pre-
vious myocardial infarction, six had cardiomyopathy and 
one had mitral valve prolapse syndrome. 
Drug treatment. For this study, 30 of 54 patients re-
ceived quinidine, 24 procainamide and 30 disopyramide. 
Some patients were studied taking more than one agent, 
each used separately. The mean daily dosage of quinidine 
was 1,600 ± 210 mg, procainamide 4,000 ± 885 mg and 
disopyramide 933 ± 308 mg. 
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Table 1. Results of Ambulatory Electrocardiographic Monitoring in 54 Patients 
Quinidine (n = 30) Procainamide (n = 24) Disopyramide (n = 30) 
Pre-Rx Post-Rx Pre-Rx Post-Rx Pre-Rx Post-Rx 
VPCs/h 279 ± 40 44 ± 59 355 ± 326 104 ± 166 323 ± 362 58 ± 95 
Pts. with ~83% reduction 18 (60%) 11(46%) 18 (60%) 
Pts. with ~50% reduction 24 (80%) 21 (88%) 27 (90%) 
Couplets/h 10.5 ± 28.2 0.8 ± 1.7 13.7 ± 17.4 2.4 ± 8.4 10.5 ± 15.9 3.7 ± 10.8 
Pts. with/without couplets 27/3 18/12 22/2 12/12 28/2 15/15 
Pts. with ~90% reduction 14 of 27 16 of 22 22 of 28 
VT/24 h 41.5 ± 149.2 0.7 ± 2.3 49.9 ± 157.5 3.9 ± 18.1 32.5 ± 74.4 5.1 ± 20.3 
Pts. with/without VT 19111 6/24 16/8 4/20 22/8 4/26 
Pts. with abolition of VT 13 of 19 12 of 16 18 of 22 
n = number of patients; Post after; Pre = before; Pts. = number of patients; Rx treatment; VPCs = ventricular premature complexes; 
VT = ventricular tachycardia (~ three ventricular premature complexes in a row at rate greater than 100/min). 
Ambulatory electrocardiography (Tables 1 and 2). 
Quinidine was effective in 15 (50%) of 30 patients by Holter 
criterion I, 14 (47%) of 30 by Holter criterion II and 13 
(68%) of 19 by Holter criterion III. Procainamide was ef-
fective in 10 (42%) of 24 patients by criterion I, 15 (63%) 
of 24 by criterion II and 12 (75%) of 16 by criterion III. 
Disopyramide was effective in 18 (60%) of 30 patients by 
criterion I, 24 (80%) of 30 by criterion II and 18 (82%) of 
22 by criterion III. 
Programmed stimulation (Tables 2 and 3). All 54 pa-
tients, including 3 whose first documented rhythm was ven-
tricular fibrillation, had sustained monomorphic ventricular 
tachycardia induced by one, two or three extrastimuli before 
treatment requiring rapid ventricular pacing or direct current 
cardioversion for termination. Ventricular tachycardia was 
induced by double extrastimuli during sinus rhythm in 1 
patient, by triple extrastimuli during sinus rhythm in 14, by 
single extrastimuli during ventricular pacing in 3, by double 
extrastimuli during ventricular pacing in 8 and by triple 
extrastimuli during ventricular pacing in 28 patients. Thus, 
ventricular tachycardia was induced by one or two extra-
stimuli in only 12 patients (22%), by three extrastimuli 
during sinus rhythm in 14 patients (26%) and by three ex-
trastimuli during ventricular pacing in 28 patients (52%). 
Treatment was effective by programmed stimulation cri-
teria in 8 (27%) of 30 patients taking quinidine, 5 (21 %) 
of 24 taking procainamide and 8 (27%) of 30 taking diso-
pyramide. In patients who had inducible ventricular tachy-
cardia after treatment, the cycle length of induced ventric-
ular tachycardia was significantly (p < 0.05) longer after 
treatment compared with baseline study. 
Concordance between programmed stimulation and 
Holter monitoring (Table 4). Efficacy of treatment deter-
mined by programmed stimulation criteria was compared 
with efficacy determined by the three Holter criteria. As-
sessments of efficacy by programmed stimulation and by 
Holter monitoring criterion I were concordant in 42 treat-
ments (50%) and discordant in 42 (50%). Programmed stim-
ulation and Holter criterion II assessments were concordant 
in 46% and discordant in 54%. Programmed stimulation and 
Holter criterion III assessments were concordant in 39% and 
discordant in 61 %. When quinidine, procainamide and di-
sopyramide were considered individually, similar rates of 
discordance were noted. By Holter criterion I, discordance 
was noted in 57% of the patients taking quinidine, 37% of 
those taking procainamide and 53% of those taking diso-
pyramide. By Holter criterion II, discordance was noted in 
53% of the patients taking quinidine, 50% of those taking 
procainamide and 60% of those taking disopyramide. By 
Holter criterion III, discordance was noted in 58% of the 
patients taking quinidine, 50% of those taking procainamide 
and 73% of those taking disopyramide. 
In the majority of the discordant results, a treatment was 
considered effective by Holter criteria but ineffective by 
programmed stimulation criteria. Using Holter criterion I, 
in 32 (76%) of 42 discordant assessments treatment was 
considered effective by Holter monitoring but ineffective 
by programmed stimulation, whereas in 10 (24%) treatment 
Table 2. Efficacy of Treatment Determined by Programmed Stimulation and Holter Monitoring 
Quinidine Procainamide Disopyramide All Treatments 
Programmed stimulation 8 (26%) 5 (21%) 8 (26%) 21 (25%) 
Holter criterion 1* 15 (50%) 10 (42%) 18 (60%) 43 (51%) 
Holter criterion 1I* 14 (47%) 15 (63%) 24 (80%) 53 (63%) 
Holter criterion III* 13 (68%) 12 (75%) 18 (82%) 43 (75%) 
*See text for description of the three Holter efficacy criteria. 
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Table 3. Results of Programmed Stimulation in 54 Patients 
Quinidine (n = 30) 
Pre-Rx Post-Rx 
Pts. with VT induced by PES* 30 22 
SR + I PES 0 0 
SR + 2 PES I 
SR + 3 PES 6 4 
VP + I PES 3 0 
VP + 2 PES 7 8 
VP + 3 PES 13 9 
VT cycle length (ms) 280 ± 58 335 ± 67 








256 ± 55 312 ± 57 
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273 ± 55 388 ± 88 
* All patients had inducible sustained ventricular tachycardia before treatment. After treatment, the number of patients with sustained ventricular 
tachycardia or tachycardia longer than 15 beats are shown. PES = programmed extrastimuli; SR = sinus rhythm; VP = ventricular pacing; other 
abbreviations as in Table I. 
was ineffective by Holter monitoring but effective by pro-
grammed stimulation. Using Holter criterion II, treatment 
was considered effective by Holter monitoring in 39 (85%) 
of 46 discordant assessments but in only 7 (15%) by pro-
grammed stimulation. By Holter criterion III, treatment was 
effective by Holter monitoring in 32 (91 %) of 35 discordant 
assessments and in only 3 (9%) by programmed stimulation 
criteria. Thus, Holter monitoring and programmed stimu-
lation were discordant in more than 50% of efficacy as-
sessments. When the two methods were discordant, it was 
more likely that a treatment was judged effective by Holter 
criteria than by programmed stimulation criteria (p < 0.001 
by McNemar's test). 
Discussion 
Our study suggests that I) assessment of efficacy of class 
lA antiarrhythmic agents determined by programmed stim-
ulation and Holter monitoring is often discordant; 2) treat-
ment is considered effective more frequently by Holter cri-
teria than by programmed stimulation criteria; and 3) treatment 
considered to be ineffective by programmed stimulation is 
often considered effective by Holter criteria. 
Patients with fewer than 30 ventricular premature com-
plexes/h were excluded from this study because it is the 
consensus (1,12) that such patients should be managed by 
programmed stimulation rather than by Holter monitoring. 
Programmed stimulation protocol: role of triple ex-
trastimuli. The specificity of polymorphic nonsustained 
ventricular tachycardia induced by triple extrastimuli has 
been questioned in patients whose documented ventricular 
tachycardia is monomorphic (13,14). However, in a sig-
nificant number of patients with recurrent ventricular tachy-
cardia, triple extrastimuli are necessary to induce clinical 
arrhythmia and this is considered to be specific (l 0,13, 
14,16,17). In our study, most patients required triple ex-
Table 4. Correlation Between Efficacy of Treatments Determined by Programmed Stimulation and Holter Monitoring 
Q (n = 30) PA (n = 24) D (n = 30) All Treatments (n = 84) 
PES vs. Holter 1*: concordance (Rx effective by both) 3 3 5 II (13%) 
PES vs. Holter I: concordance (Rx ineffective by both) 10 12 9 31 (37%) 
PES vs. Holter I: discordance (effective only by Holter) 12 7 13 32 (38%) 
PES vs. Holter I: discordance (effective only by PES) 5 2 3 10 (12%) 
Discordance by McNemar's test p < 0.2t p < 0.2t p < 0.Q25 P < 0.001 
PES vs. Holter 11*: concordance (Rx effective by both) 3 4 7 14 (17%) 
PES VS. Holter II: concordance (Rx ineffective by both) II 8 5 24 (29%) 
PES vs. Holter II: discordance (effective only by Holter) II II 17 39 (46%) 
PES vs. Holter II: discordance (effective only by PES) 5 7 (8%) 
Discordance by McNemar's test p < 0.2t p < 0.01 p < 0.001 P < 0.001 
Q (n = 19) PA (n = 16) D (n = 22) All (n = 57) 
PES vs. Holter 111*: concordance (Rx effective by both) 4 3 3 10 (18%) 
PES VS. Holter III: concordance (Rx ineffective by both) 4 5 3 12 (21%) 
PES vs. Holter III: discordance (effective only by Holter) 9 8 15 32 (56%) 
PES vs. Holter III: discordance (effective only by PES) 2 0 3 (5%) 
Discordance by McNemar's test p < O. It p < 0.01 p < 0.005 P < 0.001 
*See text for efficacy criteria by programmed stimulation and Holter monitoring; tp = NS. D = disopyramide; PA = procainamide; Q = quinidine; 
other abbreviations as in Tables I and 3. 
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trastimuli for induction of sustained ventricular tachycardia 
during baseline study in the absence of antiarrhythmic drugs. 
Therefore, efficacy by programmed stimulation was defined 
as noninducibility of ventricular tachycardia or occurence 
of nonsustained ventricular tachycardia (:s: 15 beats) after 
three extrastimuli. The reason most of our patients required 
three extrastimuli for induction of ventricular tachycardia 
during baseline study is unclear. It may be related to the 
stimulation protocol or the patient group at our institution. 
Holter monitoring. Because of spontaneous variability 
in ventricular arrhythmia (15), a longer period of monitoring 
(such as 72 hours) could possibly have affected the results 
of the study; however, the rigor of our efficacy criteria and 
the fact that all patients had Holter monitoring for at least 
24 hours, often for 48 hours, probably minimize the effect 
of spontaneous variability. Efficacy criteria used in this study 
(see Methods section) are used wielely by many investigators 
(1-10,15,16). 
Discordance between programmed stimulation and 
Holter monitoring. This study suggests discordance be-
tween these two methods in evaluating efficacy of class IA 
antiarrhythmic agents. Concordance (effective or ineffective 
by both methods) was noted in less than 50% of the treat-
ments. There are several inferences to be drawn from the 
discordant results seen in this study. Because the predictive 
value of efficacy by Holter monitoring has been reported to 
be very good (1-4), as has the predictive value of pro-
grammed stimulation (5-10), the discordance between the 
two methods is difficult to explain. When the two methods 
were discordant, a treatment was more likely to be effective 
by Holter criteria than by programmed stimulation criteria. 
This may suggest poor sensitivity (false efficacy) of suppres-
sion of ventricular premature complexes or poor specificity 
(false inefficacy) of ventricular tachycardia induced by pro-
grammed stimulation, or both, in a patient taking a class 
IA antiarrhythmic agent. 
Poor specificity of ventricular tachycardia induced by 
programmed stimulation in patients taking amiodarone has 
been reported (18,19). However, there have been no pre-
vious reports of poor specificity of ventricular tachycardia 
induced by programmed stimulation in patients taking a 
class IA agent. Platia and Reid (II) reported a poor pre-
dictive value of negative results of ambulatory monitoring 
compared with negative results on programmed stimulation. 
However, as they noted, their study had major limitations. 
Ambulatory electrocardiographic monitoring and pro-
grammed stimulation were performed only on the discharge 
regimen, but not before treatment. Because a significant 
number of patients with recurrent ventricular tachycardia or 
fibrillation have negative results on Holter monitoring (with-
out frequent or high grade ventricular premature complexes) 
even before treatment (1,12), many patients who had neg-
ative findings on ambulatory monitoring on the discharge 
regimen might also have had negative findings on ambu-
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latory monitoring before treatment and should have been 
excluded in determining the predictive value of a negative 
Holter recording. Similar arguments may apply to pro-
grammed stimulation. To assess the value of a negative test 
result (using programmed stimulation or Holter monitoring) 
in determining efficacy of antiarrhythmic agents, the test 
must be performed before treatment with antiarrhythmic 
agents to exclude the patients with a negative test result 
before treatment. 
In brief, there are no studies that adequately compare the 
predictive accuracies of Holter monitoring and programmed 
stimulation in the assessment of efficacy of class IA an-
tiarrhythmic agents. Our stuely was not designed to answer 
this important question. Although one might be more con-
fident about efficacy or inefficacy of a treatment when results 
of Holter monitoring and programmed stimulation are co'1-
cordant, discordance between the two tests poses a dilemma 
in patient management. Independent studies of these two 
methods may be influenced by such factors as selection 
criteria, variations in stimulation protocol, investigator bias 
and differences in follow-up management. Thus, the ques-
tion of which method offers a superior predictive accuracy 
can only be answered by a concurrent, randomized trial with 
long-term clinical follow-up. 
Our study involved selected patients, mostly with coro-
nary artery disease, with frequent ventricular premature 
complexes and inducible ventricular tachycardia. The results 
may be different in different patient groups taking a different 
class of antiarrhythmic agents. Further study will be nec-
essary to answer this question. 
Conclusion~. In patients with inducible sustained ven-
tricular tachycardia and frequent ventricular premature com-
plexes before treatment: I) programmed stimulation and 
Holter monitoring are often discordant in assessing efficacy 
or inefficacy of procainamide, quinidine and disopyramide; 
2) efficacy by Holter criteria is often easier to achieve than 
efficacy by programmed stimulation; and 3) the discordance 
between the two methods, both with very good reported 
predictive values, calls for long-term randomized clinical 
follow-up studies to determine sensitivity and specificity of 
each method. 
We express our appreciation to Robin Simak for her secretarial assistance 
in the preparation of this manuscript. 
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